Theratechnologies, a Montreal-based pharmaceutical company, is grappling with an unexpected supply disruption of its HIV medication Egrifta SV. This drug, which serves to reduce excess abdominal fat in HIV patients with lipodystrophy, has encountered a significant hurdle stemming from the
In an unprecedented move set to revolutionize emergency cardiac care, Asamedic and Bormioli Pharma have formed a groundbreaking partnership to commercialize Coxor, a 300mg Acetylsalicylic acid medication designed for the urgent treatment of suspected acute myocardial infarction. Unlike traditional
Recipharm's latest innovation in the pharmaceutical industry, ReciPredict, is poised to revolutionize the drug development landscape. This cutting-edge platform is designed with Quality by Design (QbD) principles at its core, aiming to streamline tech transfers and manufacturing processes. By
In a significant strategic decision reflective of shifting priorities within the pharmaceutical industry, GSK has announced that it will close its 75-year-old antibiotics manufacturing facility in Ulverston, UK, by 2024. This move comes in the wake of the expiration of the company’s contract to
Advancements in deep technology are revolutionizing the pharmaceutical industry, bringing transformative changes across drug discovery, manufacturing, clinical trials, and distribution. By leveraging technologies such as artificial intelligence (AI), blockchain, and quantum computing, the
Renaissance Lakewood LLC, a prominent pharmaceutical contract development and manufacturing organization (CDMO), recently completed a significant campus enhancement project, fortifying its facilities and operational capabilities in Lakewood, NJ. This massive project marks a milestone for the
